Ovid Therapeutics Inc.
OVID | NASDAQ
$2.79
+$0.08 (+2.95%)
Sep 22, 2026, 1:49 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.58M | 7.12M | 7.25M | 6.61M | 6.65M | 548K | 566K | 632K | 568K | 474K | 392K | 296.28K | 198.38K | 123.38K | 1.5M | 1.46M | 1.45M | 1.45M | 208.38M | 214.09M | 221M | 221M |
Cost of Revenue | 35K | 35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 56.87K | 56.87K | 56.87K | 56.87K | n/a | n/a | n/a |
Gross Profit | 1.55M | 7.09M | 7.25M | 6.61M | 6.65M | 548K | 566K | 632K | 568K | 474K | 392K | 296.28K | 198.38K | 123.38K | 1.5M | 1.4M | 1.39M | 1.39M | 208.33M | 214.09M | 221M | 221M |
Operating Income | -58.36M | -47.74M | -42.44M | -40.87M | -41.57M | -57.02M | -61.88M | -69.35M | -68.15M | -61.81M | -59.28M | -53.27M | -54.04M | -54.17M | -55.55M | -69.73M | -68.61M | -68.62M | 124.21M | 128.97M | 124.25M | 115.42M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 590.49K |
Pretax Income | -34.49M | -24.17M | -17.41M | -36.33M | -38.18M | -24.97M | -26.43M | -32.5M | -29.75M | -50.68M | -52.34M | -48.52M | -49.24M | -51.42M | -54.12M | -68.96M | -68.68M | -68.4M | 124.16M | 128.48M | 123.74M | 115.5M |
Net Income | -34.49M | -24.17M | -17.41M | -36.33M | -38.18M | -24.97M | -26.43M | -32.5M | -29.75M | -50.68M | -52.34M | -48.52M | -49.24M | -51.42M | -54.17M | -67.81M | -67.23M | -68.43M | 123.68M | 126.81M | 121.76M | 115M |
Selling & General & Admin | 26.35M | 24.75M | 24.11M | 24.46M | 23.22M | 26.44M | 27.59M | 27M | 28.26M | 27.41M | 28.58M | 29.76M | 30.59M | 31.6M | 33.13M | 34M | 33.13M | 31.51M | 37.2M | 39.38M | 40.06M | 40.54M |
Research & Development | 33.56M | 30.07M | 25.58M | 24.92M | 26.9M | 33.02M | 36.76M | 41.48M | 38.95M | 32.37M | 28.59M | 23.5M | 23.35M | 23.4M | 24.62M | 37.13M | 36.86M | 38.5M | 46.92M | 45.13M | 56.09M | 64.44M |
Other Expenses | n/a | n/a | n/a | -1.9M | -1.9M | -1.9M | -1.9M | 1.5M | 1.5M | 2.5M | 2.5M | 299K | 298.71K | -700.68K | -699.48K | 525 | 1.16K | -298 | 53 | 600.05K | 599.71K | 600.55K |
Operating Expenses | 59.91M | 54.82M | 49.69M | 47.48M | 48.22M | 57.56M | 62.45M | 69.98M | 68.72M | 62.28M | 59.67M | 53.56M | 54.24M | 54.3M | 57.05M | 71.13M | 70M | 70M | 84.12M | 85.11M | 96.75M | 105.58M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 59.94M | 54.86M | 49.69M | 47.48M | 48.22M | 57.56M | 62.45M | 69.98M | 68.72M | 62.28M | 59.67M | 53.56M | 54.24M | 54.3M | 57.05M | 71.19M | 70.05M | 70.06M | 84.17M | 85.11M | 96.75M | 105.58M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | -299.71K | -594.54K | 878.54K | 1.33M | 1.68M | 1.97M | 500.28K |
Shares Outstanding (Basic) | 197.45M | 73.74M | 81.67M | 71.11M | 71.11M | 71.05M | 71.01M | 70.98M | 70.92M | 70.72M | 70.69M | 70.62M | 70.53M | 70.3M | 70.47M | 70.4M | 69.47M | 70.04M | 67.51M | 66.97M | 67.82M | 66.09M |
Shares Outstanding (Diluted) | 197.45M | 73.74M | 81.67M | 71.11M | 71.11M | 71.05M | 71.01M | 70.98M | 71.2M | 70.72M | 70.69M | 70.62M | 70.53M | 70.49M | 70.47M | 70.43M | 70.39M | 70.35M | 68.16M | 67.93M | 67.82M | 66.58M |
EPS (Basic) | -0.36 | -0.35 | -0.26 | -0.51 | -0.54 | -0.35 | -0.38 | -0.47 | -0.43 | -0.73 | -0.75 | -0.69 | -0.69 | -0.72 | -0.76 | -0.98 | -0.99 | -1.01 | 1.77 | 1.80 | 1.69 | 1.51 |
EPS (Diluted) | -0.36 | -0.35 | -0.26 | -0.51 | -0.54 | -0.35 | -0.38 | -0.47 | -0.43 | -0.73 | -0.75 | -0.69 | -0.69 | -0.72 | -0.76 | -0.98 | -0.99 | -1.01 | 1.75 | 1.79 | 1.68 | 1.50 |
EBITDA | -35.8M | -24M | -17.14M | -37.58M | -39.28M | -26.02M | -27.49M | -33.07M | -30.34M | -52.05M | -55.24M | -51.58M | -52.86M | -53.68M | -55.12M | -68.73M | -67.97M | -68.38M | 124.45M | 129.23M | 124.54M | 115.74M |
EBIT | -35.87M | -24.17M | -17.41M | -38M | -39.85M | -26.64M | -28.1M | -33.67M | -30.91M | -52.61M | -55.81M | -52.19M | -53.74M | -54.87M | -56.25M | -69.72M | -68.6M | -68.61M | 124.21M | 128.97M | 124.25M | 115.42M |
Depreciation & Amortization | 68K | 167K | 273K | 416K | 569K | 618K | 613K | 593K | 570K | 559K | 568K | 612.98K | 882.35K | 1.2M | 1.13M | 998.53K | 635.34K | 236.07K | 237K | 263.17K | 289.91K | 314.71K |
Add to Watchlist
Select watchlists to add or remove OVID